BioSpace News Archive

Cushman & Wakefield and Lee & Associates Broker the Deal

Kali, Inc. today announced publishing a new website and hosting an online shareholder presentation from the new website.

Topline results show reduction in LGCS, a standard measure in this indication, at 3 months from baseline

Newly-developed website to serve as a resource for Asia-Pacific (APAC) medical device sponsors.

The platforms aim to assist in the diagnosis and treatment of breast cancer and heart disease

Swedish Orphan Biovitrum AB today announce that the US Food and Drug Administration (FDA) has approved Gamifant® (emapalumab-lzsg), an interferon gamma (IFNγ) blocking antibody for the treatment of paediatric (new born and older) and adult patients with primary haemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance to conventional HLH therapy.

Takeda Pharmaceutical Company Limited (“Takeda”) announces that it has received clearance from the European Commission (the “EC”) for the proposed acquisition of Shire plc (“Shire”) announced on May 8, 2018 (the “Acquisition”).

MRI brain scans perform better than common clinical tests at predicting which people will go on to develop Alzheimer’s disease, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

Shanghai Roche Pharmaceuticals Ltd. and Ascletis BioScience Co., Ltd. jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis.